294659-72-6

Basic information

• Product Name: TERT-BUTYL (6-CHLORO-3-FORMYLPYRIDIN-2-YL)CARBAMATE
• Synonyms: TERT-BUTYL (6-CHLORO-3-FORMYLPYRIDIN-2-YL)CARBAMATE;(6-Chloro-3-formyl-pyridin-2-yl)-carbamic acid tert-butyl ester
• CAS NO: 294659-72-6
• Molecular Formula: C₁₁H₁₃ClN₂O₃
• Molecular Weight: 256.69
• Mol File: 294659-72-6.mol
• Article Data: 8

Chemical Properties

• Appearance: /
• Storage Temp.: under inert gas (nitrogen or Argon) at 2-8°C
• CAS DataBase Reference: TERT-BUTYL (6-CHLORO-3-FORMYLPYRIDIN-2-YL)CARBAMATE(CAS DataBase Reference)
• NIST Chemistry Reference: TERT-BUTYL (6-CHLORO-3-FORMYLPYRIDIN-2-YL)CARBAMATE(294659-72-6)
• EPA Substance Registry System: TERT-BUTYL (6-CHLORO-3-FORMYLPYRIDIN-2-YL)CARBAMATE(294659-72-6)

Safety Data

• Hazardous Substances Data: 294659-72-6(Hazardous Substances Data)

Usage

General Description

TERT-BUTYL (6-CHLORO-3-FORMYLPYRIDIN-2-YL)CARBAMATE is a chemical compound with the formula C13H16ClN3O3. It is a carbamate derivative with a tert-butyl substituent attached to the nitrogen atom and a pyridine ring with a chloro and formyl group attached to the carbon atoms. This chemical is commonly used as a reagent in organic synthesis and pharmaceutical research. It may also have potential applications in the field of agriculture as a pesticide or herbicide. Additionally, it has been studied for its potential pharmacological activities and biological effects. However, due to its structural complexity and potential toxicity, it requires careful handling and further research to fully understand its properties and potential uses.

InChI:InChI=1S/C11H13ClN2O3/c1-11(2,3)17-10(16)14-9-7(6-15)4-5-8(12)13-9/h4-6H,1-3H3,(H,13,14,16)

Upstream product

• 45644-21-1 6-chloropyridin-2-amine 
• 24424-99-5 di-tert-butyl dicarbonate 
• 5350-93-6 6-Chloro-pyridin-3-ylamine 
• 159603-71-1 t-butyl N-(6-chloro-2-pyridinyl)carbamate 
• 68-12-2 N,N-dimethyl-formamide 

Downstream Products

• 294659-75-9 tert-butyl 3-[6-chloro-2-(tert-butoxycarbonylamino)-3-pyridyl]-2-(2,6-dichlorophenyl)-3-hydroxypropanoate 
• 1386448-12-9 tert-butyl 3-(3-(7-methoxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamido)-4-methylbenzamido)-3-phenylpropylcarbamate 
• 1386448-11-8 tert-butyl 3-(4-chloro-3-(7-methoxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamido)benzamido)-3-phenylpropylcarbamate 
• 1386448-10-7 3-(7-methoxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamido)-4-methylbenzoic acid 
• 1386448-09-4 4-chloro-3-(7-methoxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamido)benzoic acid 
• 1386447-57-9 3-{[7-(4-Methyl-piperazin-1-yl)-2-oxo-1,2-dihydro-[1,8]naphthyridine-3-carbonyl]-amino}-benzoic acid methyl ester 
• 678138-43-7 2-amino-6-methoxy-pyridine-3-carbaldehyde 
• 1386447-68-2 N-(5-(3-amino-1-phenylpropylcarbamoyl)-2-chlorophenyl)-7-methoxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide 
• 1386447-67-1 N-(5-(3-amino-1-phenylpropylcarbamoyl)-2-methylphenyl)-7-methoxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide 
• 1386447-66-0 N-(5-(3-chlorobenzylcarbamoyl)-2-methylphenyl)-7-methoxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide 
• 1386447-65-9 N-(5-(benzylcarbamoyl)-2-methylphenyl)-7-methoxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide 
• 1386447-64-8 N-(2-chloro-5-(3-chlorobenzylcarbamoyl)phenyl)-7-methoxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide 
• 1386447-63-7 N-(5-(benzylcarbamoyl)-2-chlorophenyl)-7-methoxy-2-oxo-1,2-dihydro-1,8-naphthyridine-3-carboxamide 
• 1386447-61-5 4-Chloro-3-[(7-methoxy-2-oxo-1,2-dihydro-[1,8]naphthyridine-3-carbonyl)-amino]-benzoic acid methyl ester 

Relevant articles and documents

Pyridoazepine derivative, pharmaceutical composition and applications thereof

The present invention discloses a pyridoazepine derivative, a pharmaceutical composition and applications thereof, wherein the pyridoazepine derivative (I), the isomer, the prodrug, the stable isotopederivative or the pharmaceutically acceptable salt thereof have the following structure. According to the present invention, the pyridoazepine derivative has good regulatory effects on TLR family andrelated signaling pathways, particularly on TLR8, can effectively treat, alleviate and/or prevent various diseases mediated by signaling pathways related to TLR family and TLR, and particularly can effectively treat, alleviate and/or prevent various TLR8 mediated diseases such as cancers, autoimmune diseases, infections, inflammations, transplant rejections, graft versus host diseases and the like. The formula (I) is defined in the specification.

IMIDAZO-, PYRAZOLOPYRAZINES AND IMIDAZOTRIAZINES AND THEIR USE

The invention relates to substituted imidazo-, pyrazolopyrazines and imidazotriazines and processes for their preparation, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, in particular of hematological di

SUBSTITUTED PYRIDINES, AND USE THEREOF AS GSK3 INHIBITORS

The invention relates to substituted pyridines and to processes for preparation thereof, and to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of haematological disorders, preferably of leukopenia and neutropenia